Logo for BetterLife Pharma  Inc.
BETR

BetterLife Pharma Inc.

Status
Active
Issued & Outstanding113,825,305
Reserved for Issuance11,120,000
Currency
CSE Index

About

BetterLife Pharma Inc.

Listing date
December 19, 2017
Social

BetterLife Pharma Inc. (“BetterLife”) is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, Altum Pharmaceuticals Inc., BetterLife is refining and developing drug candidates from a broad set of complementary Interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.